XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating activities    
Net income $ 165,674 $ 146,031
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 17,947 15,020
Amortization 1,132 1,288
Share-based compensation 9,496 7,373
Excess tax benefits from share-based compensation 0 (6,582)
Equity earnings in unconsolidated investments, net (121) (113)
Other 1,074 3,799
Changes in operating assets and liabilities, net of effects of acquisitions:    
Receivables (90,204) (71,936)
Product inventories 9,057 23,624
Prepaid expenses and other assets (1,523) (1,094)
Accounts payable (27,328) (49,479)
Accrued expenses and other current liabilities 26,816 75,239
Net cash provided by operating activities 112,020 143,170
Investing activities    
Acquisition of businesses, net of cash acquired (6,879) (19,314)
Purchase of property and equipment, net of sale proceeds (37,709) (30,388)
Payments to fund credit agreement 0 (3,852)
Collections from credit agreement 0 3,300
Other investments, net 4 21
Net cash used in investing activities (44,584) (50,233)
Financing activities    
Proceeds from revolving line of credit 918,338 873,854
Payments on revolving line of credit (857,609) (866,801)
Proceeds from asset-backed financing 156,600 145,000
Payments on asset-backed financing (97,800) (90,000)
Proceeds from short-term borrowings, long-term debt and other long-term liabilities 25,001 15,705
Payments on short-term borrowings, long-term debt and other long term liabilities (17,497) (16,107)
Payments of deferred and contingent acquisition consideration (199) 0
Payments of deferred financing costs (909) 0
Purchase of redeemable noncontrolling interest (2,573) 0
Excess tax benefits from share-based compensation 0 6,582
Proceeds from stock issued under share-based compensation plans 8,647 10,978
Payments of cash dividends (43,165) (37,007)
Purchases of treasury stock (141,580) (117,901)
Net cash used in financing activities (52,746) (75,697)
Effect of exchange rate changes on cash and cash equivalents (248) (185)
Change in cash and cash equivalents 14,442 17,055
Cash and cash equivalents at beginning of period 21,956 13,237
Cash and cash equivalents at end of period $ 36,398 $ 30,292